Eli Lilly and Co (LTS:0Q1G)
CHF 540 0 (0%) Market Cap: 659.26 Bil Enterprise Value: 680.71 Bil PE Ratio: 113.50 PB Ratio: 56.21 GF Score: 81/100

Eli Lilly and Co to Discuss World Conference on Lung Cancer Presentation Transcript

Sep 09, 2019 / 05:00PM GMT
Release Date Price: CHF111.44
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot